Teva Pharmaceuticals Upgraded to Ba1 Credit Rating by Moody's Amid Successful Growth Strategy

Reuters
2025.05.15 22:12
portai
I'm PortAI, I can summarize articles.

Teva Pharmaceuticals Upgraded to Ba1 Credit Rating by Moody's Amid Successful Growth Strategy Teva Pharmaceutical Industries Ltd. has received an upgrade in its corporate credit rating from Moody's Investor Services, moving from Ba2 with a positive outlook to Ba1 with a stable outlook. This change reflects Teva's significant global scale, growth in branded franchises, stabilization of its generics business, focus on debt reduction, and resolution of legal liabilities. The upgrade is anticipated to benefit Teva's cost of debt and investor base.

Teva Pharmaceutical Industries Ltd. has received an upgrade in its corporate credit rating from Moody's Investor Services, moving from Ba2 with a positive outlook to Ba1 with a stable outlook. This change reflects Teva's significant global scale, growth in branded franchises, stabilization of its generics business, focus on debt reduction, and resolution of legal liabilities. The upgrade is anticipated to benefit Teva's cost of debt and investor base.

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.